The Efectiveness of Atorvastatin for The Prevention of Deep Vein Thrombos…

Background Deep vein thrombosis (DVT) is a common complication in cancer. Although thromboprophylaxis in cancer patients is recommended by the guidelines, clinicians’ use of thromboprophylaxis remains limited due to cost, bleeding complications, and reluctance to give injectable anticoagulants. Infammation plays essential roles in the pathogenesis of cancer-associated thrombosis. Owing to …